AR006308A1 - Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador. - Google Patents

Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.

Info

Publication number
AR006308A1
AR006308A1 ARP970100422A ARP970100422A AR006308A1 AR 006308 A1 AR006308 A1 AR 006308A1 AR P970100422 A ARP970100422 A AR P970100422A AR P970100422 A ARP970100422 A AR P970100422A AR 006308 A1 AR006308 A1 AR 006308A1
Authority
AR
Argentina
Prior art keywords
composition
biologically effective
effective compound
dispensing system
aqueous
Prior art date
Application number
ARP970100422A
Other languages
English (en)
Original Assignee
Cosmoferm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27443289&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR006308(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cosmoferm Bv filed Critical Cosmoferm Bv
Publication of AR006308A1 publication Critical patent/AR006308A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
    • B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
    • B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
    • B05B11/1081—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping
    • B05B11/1084—Arrangements for pumping several liquids or other fluent materials from several containers, e.g. for mixing them at the moment of pumping each liquid or other fluent material being pumped by a separate pump

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Un sistemas dispensador que permite la aplicación de una composición acuosa que contiene un compuesto biológicamente efectivo estabilizadoadecuadamente. Se utiliza un sistema dispensador de dos cámaras en donde están contenidas de forma sseparada una composición que comprende uncompuesto biológicamente efectivo y una composición básica acuosa. El sistema dispensador entrega ambas composiciones simultáneamente, con lo cual lascomposiciones se mezclan para dar como resultado una composición final adecuada para una aplicación directa, de dicho compuesto biológicamenteefectivo en su forma activa. La primer y segunda composición se entregan en una relación que varía de 1:1 a 1:50. Adicionalmente la composición puedec omprenderotro ingrediente activo. También puede contener agentes para aumentar la viscosidad. El compuesto biológicamente activo son inestablesen la formulación acuosa final en la cual se debería aplicar. Preferentemente dichos compuestos pueden ser enzimas,antibióticos, vitaminas,dihidroxiacetonas, etc. Se refiere también a un método para estabilizar físicamente una composición que comprende adicionar un agente para aumentarla viscosidad a la composición de un compuesto biol ógicamente efectivoformulado en forma de partículas. Otro objeto es una composición acuosaque comprende el compuesto biológicamente efectivo. Finalmente describe el uso del sistema dispensador para el empleo de aplicaciones tópicas del compuesto biológicamenteefectivo.
ARP970100422A 1996-01-31 1997-02-03 Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador. AR006308A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP96200190 1996-01-31
EP96200594 1996-03-08
EP96201713 1996-06-21
EP96202781 1996-10-03

Publications (1)

Publication Number Publication Date
AR006308A1 true AR006308A1 (es) 1999-08-25

Family

ID=27443289

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970100422A AR006308A1 (es) 1996-01-31 1997-02-03 Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.

Country Status (16)

Country Link
US (1) US6117433A (es)
EP (1) EP0817613B1 (es)
JP (1) JPH11503465A (es)
KR (1) KR100517060B1 (es)
CN (1) CN1140261C (es)
AR (1) AR006308A1 (es)
AT (1) ATE291897T1 (es)
AU (1) AU1721697A (es)
BR (1) BR9702049B1 (es)
CA (1) CA2216169C (es)
DE (1) DE69732881T2 (es)
ES (1) ES2237789T3 (es)
ID (1) ID18666A (es)
MX (1) MX9707487A (es)
PT (1) PT817613E (es)
WO (1) WO1997027841A1 (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5947335A (en) * 1996-10-15 1999-09-07 Lever Brothers Company Dual compartment package
US6082588A (en) * 1997-01-10 2000-07-04 Lever Brothers Company, Division Of Conopco, Inc. Dual compartment package and pumps
WO1999002133A2 (en) * 1997-07-08 1999-01-21 Dsm N.V. Topical application of a combination of benzoyl peroxide and a second active ingredient
KR100351620B1 (ko) * 1999-07-09 2002-09-10 주식회사대성미생물연구소 3차 결정구조의 내열성 효소
KR100340086B1 (ko) * 1999-08-27 2002-06-12 안용찬 비듬방지용 샴푸조성물
US6585984B1 (en) * 2000-03-03 2003-07-01 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Dual composition cosmetic product with a concentration sensitive and an incompatible active respectively placed within first and second compositions
WO2001080827A2 (en) * 2000-04-21 2001-11-01 Nature's Cure Salicylic acid acne spray formulations and methods for treating acne with same
MXPA03002167A (es) * 2000-09-13 2003-07-24 Procter & Gamble Metodo cosmetico.
US20030206897A1 (en) * 2000-09-13 2003-11-06 The Procter & Gamble Company Cosmetic compositions
AU2000274826A1 (en) * 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic compositions
MXPA03002166A (es) * 2000-09-13 2003-07-24 Procter & Gamble Metodo cosmetico para tratar la piel y/o el cabello.
AU2000274825A1 (en) * 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic method
AU2000274827A1 (en) * 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic compositions
JP2002326924A (ja) * 2001-05-07 2002-11-15 Hayashibara Biochem Lab Inc 洗顔料
US7364565B2 (en) * 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
GB0126433D0 (en) * 2001-11-03 2002-01-02 Astrazeneca Ab Compounds
JP2005515176A (ja) * 2001-11-03 2005-05-26 アストラゼネカ アクチボラグ 抗腫瘍剤としてのキナゾリン誘導体
CA2416305A1 (en) * 2002-01-31 2003-07-31 Davies, John Shaving, after-shave, and skin conditioning compositions
US20080152613A1 (en) * 2002-01-31 2008-06-26 Norburn Robert B Method for manufacturing a skin care composition
US20080152722A1 (en) * 2002-01-31 2008-06-26 Norburn Robert B Skin care composition
TWI324597B (en) * 2002-03-28 2010-05-11 Astrazeneca Ab Quinazoline derivatives
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
FR2840215B1 (fr) * 2002-06-03 2004-08-27 Oreal Composition contenant un actif susceptible d'etre oxyde par un hydroperoxyde, une lipoxygenase et un substrat et procede mettant en oeuvre cette composition
DE10241073A1 (de) * 2002-09-05 2004-03-11 Beiersdorf Ag Kosmetikum mit aktivierbaren Pflegekomponenten
GB0309009D0 (en) * 2003-04-22 2003-05-28 Astrazeneca Ab Quinazoline derivatives
GB0309850D0 (en) * 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
ATE446969T1 (de) * 2003-08-20 2009-11-15 Seikagaku Kogyo Co Ltd Stabilisierungsmittel für enzyme
DE10342211A1 (de) * 2003-09-12 2005-04-07 Beiersdorf Ag Kosmetikum
GB0321648D0 (en) * 2003-09-16 2003-10-15 Astrazeneca Ab Quinazoline derivatives
US20070032508A1 (en) * 2003-09-16 2007-02-08 Bradbury Robert H Quinazoline derivatives as tyrosine kinase inhibitors
WO2005028469A1 (en) * 2003-09-19 2005-03-31 Astrazeneca Ab Quinazoline derivatives
CN1882570B (zh) * 2003-09-19 2010-12-08 阿斯利康(瑞典)有限公司 喹唑啉衍生物
KR20060100388A (ko) * 2003-09-25 2006-09-20 아스트라제네카 아베 퀴나졸린 유도체
WO2005032729A1 (ja) * 2003-10-03 2005-04-14 Kao Corporation 吐出装置
DE602004020910D1 (de) * 2003-10-10 2009-06-10 Cosmedical Aps Haarwuchshemmung
WO2005044218A1 (en) * 2003-10-31 2005-05-19 The Procter & Gamble Company Method of providing a blended composition
GB0326459D0 (en) * 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
AU2005250224A1 (en) * 2004-06-04 2005-12-15 Astrazeneca Ab Quinazoline derivatives as ERBB receptor tyrosine kinases
JP2005350384A (ja) * 2004-06-09 2005-12-22 Blc:Kk 基礎化粧方法
BRPI0513850A (pt) * 2004-07-26 2008-05-20 Merz Pharma Gmbh & Co Kgaa composição terapêutica com uma neurotoxina botulìnica
EP1838712B8 (en) 2004-12-14 2011-10-12 AstraZeneca AB Pyrazolopyrimidine compounds as antitumor agents
MX2007010399A (es) * 2005-02-26 2007-09-25 Astrazeneca Ab Derivados de quinazolina en la forma de inhibidores de cinasa de tirosina.
GB0504474D0 (en) * 2005-03-04 2005-04-13 Astrazeneca Ab Chemical compounds
GB0508715D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
GB0508717D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Chemical compounds
US7378084B2 (en) * 2005-07-01 2008-05-27 Playtex Products, Inc. Sunless tanning composition and method of sunless tanning
WO2007017875A2 (en) * 2005-08-10 2007-02-15 Maya-Biotech Ltd. Drug delivery system for topical administration
JP2009508917A (ja) * 2005-09-20 2009-03-05 アストラゼネカ アクチボラグ 抗癌剤としてのキナゾリン誘導体
WO2007034144A1 (en) * 2005-09-20 2007-03-29 Astrazeneca Ab 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
USD543864S1 (en) 2005-09-20 2007-06-05 Cho Sean H Dual dispenser package with single actuator
USD543865S1 (en) 2005-09-20 2007-06-05 Walters Peter J Dual dispenser package with dual actuators
JP2009517451A (ja) * 2005-12-02 2009-04-30 アストラゼネカ アクチボラグ Ｅｒｂｂチロシンキナーゼの阻害剤として使用されるキナゾリン誘導体
JP2009517450A (ja) * 2005-12-02 2009-04-30 アストラゼネカ アクチボラグ チロシンキナーゼ阻害薬としての４−アニリノ置換キナゾリン誘導体
EP1921070A1 (de) * 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
EP2118075A1 (de) * 2007-02-06 2009-11-18 Boehringer Ingelheim International GmbH Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
US8569221B2 (en) * 2007-08-30 2013-10-29 Kimberly-Clark Worldwide, Inc. Stain-discharging and removing system
CA2711582A1 (en) * 2008-02-07 2009-08-13 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles, formulations containing said compounds, use thereof and processes for the preparation thereof
EP2303276B1 (en) 2008-05-13 2013-11-13 AstraZeneca AB Fumarate salt of 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(n-methylcarbamoylmethyl)piperidin-4-yl]oxy}quinazoline
CA2733153C (en) * 2008-08-08 2016-11-08 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
US20120076742A1 (en) * 2010-04-21 2012-03-29 Phillips D Howard Topical drug delivery system with dual carriers
EA031552B1 (ru) 2011-12-20 2019-01-31 Орифлейм Ресёрч Энд Девелопмент Лтд. Нетерапевтическое косметическое местное применение n-ацетил-l-аспарагиновой кислоты
US9931656B2 (en) * 2014-04-18 2018-04-03 The Clorox Company Dual chamber spray dispenser
CN107326019B (zh) * 2016-02-16 2018-05-01 上海青瑞食品科技有限公司 一种液体酶制剂及制备方法
EP3210596A1 (en) 2016-02-29 2017-08-30 G.L. Pharma GmbH Abuse-deterrent pharmaceutical composition
EP3210630A1 (en) 2016-02-29 2017-08-30 G.L. Pharma GmbH Abuse-deterrent pharmaceutical compositions
EP3231420A1 (en) 2016-02-29 2017-10-18 G.L. Pharma GmbH Abuse-deterrent pharmaceutical compositions
FR3052035B1 (fr) * 2016-06-02 2020-10-09 Oreal Systeme de distribution d'un produit cosmetique
US11000458B2 (en) 2017-03-27 2021-05-11 Evonik Operations Gmbh Method and product for producing formulations containing ceramide
KR102552770B1 (ko) * 2017-03-31 2023-07-10 (주)아모레퍼시픽 아멘토플라본의 안정도가 향상된 투명 또는 반투명 화장료 조성물
CA3060415A1 (en) 2017-04-21 2018-10-25 Phi Therapeutics, Inc. Compositions comprising propionibacterium acnes bacteriophages for treating acne
IT201900006994A1 (it) * 2019-05-20 2020-11-20 Biodermol Ambiente S R L Ceppi batterici per uso industriale
AU2020387478A1 (en) 2019-11-22 2022-06-16 Samyang Holdings Corporation Kit for preparing nanoparticle composition for drug delivery
KR20230029260A (ko) * 2021-08-24 2023-03-03 (주)아모레퍼시픽 효소 손상을 방지하는 화장료 조성물 및 이를 저장하는 화장품 용기

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6318M (es) * 1967-04-04 1968-09-23
FR2032202A5 (es) * 1969-02-21 1970-11-20 Oreal
US3834075A (en) * 1973-02-12 1974-09-10 Tre X Injector Syst Co Tree trunk pressure feeding device
US3992813A (en) * 1975-07-07 1976-11-23 Freshel David C Tree treating system
US4243543A (en) * 1979-05-11 1981-01-06 Economics Laboratory, Inc. Stabilized liquid enzyme-containing detergent compositions
US4556554A (en) * 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
AU3667189A (en) * 1988-06-23 1990-01-04 Unilever Plc Enzyme-containing liquid detergents
US4959179A (en) * 1989-01-30 1990-09-25 Lever Brothers Company Stabilized enzymes liquid detergent composition containing lipase and protease
WO1991000094A1 (en) * 1989-06-28 1991-01-10 Finn Tranberg A new papaverine injection system
EP0506791B1 (en) * 1989-12-21 1993-09-08 Novo Nordisk A/S Enzyme containing preparation and detergent containing such preparation
DE4023601A1 (de) * 1990-07-25 1992-01-30 Henkel Kgaa Fluessige enzymzubereitung
DE4121820A1 (de) * 1991-07-02 1993-01-07 Basf Ag Mikrokapseldispersionen
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US5252312A (en) * 1992-09-30 1993-10-12 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Package effervescible composition
US5827506A (en) * 1993-03-31 1998-10-27 Schering-Plough Healthcare Products, Inc. Sunless tanning method and apparatus
SK68996A3 (en) * 1993-12-03 1997-06-04 Buckman Labor Inc Enzyme stabilization by block-copolymers
US5843409A (en) * 1994-08-08 1998-12-01 Colgate Palmolive Company Two component dentifrice for the treatment of dentinal hypersensitivity
FR2725897B1 (fr) * 1994-10-24 1996-12-06 Oreal Produit pour application topique contenant une lipase et un precurseur d'actif

Also Published As

Publication number Publication date
ID18666A (id) 1998-04-30
AU1721697A (en) 1997-08-22
CN1178460A (zh) 1998-04-08
ATE291897T1 (de) 2005-04-15
CA2216169A1 (en) 1997-08-07
DE69732881T2 (de) 2006-04-06
PT817613E (pt) 2005-06-30
WO1997027841A1 (en) 1997-08-07
ES2237789T3 (es) 2005-08-01
MX9707487A (es) 1997-11-29
BR9702049A (pt) 1998-01-13
KR100517060B1 (ko) 2006-05-25
DE69732881D1 (de) 2005-05-04
JPH11503465A (ja) 1999-03-26
BR9702049B1 (pt) 2010-08-10
EP0817613A1 (en) 1998-01-14
CA2216169C (en) 2007-01-23
US6117433A (en) 2000-09-12
KR19980703467A (ko) 1998-11-05
EP0817613B1 (en) 2005-03-30
CN1140261C (zh) 2004-03-03

Similar Documents

Publication Publication Date Title
AR006308A1 (es) Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.
BR9810985A (pt) Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
PT2455083E (pt) Composição farmacêutica para aplicação dérmica compreendendo calcipotriol e betametasona para o tratamento da psoríase
GR3006146T3 (es)
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
BR0112094A (pt) Produtos de confeitaria contendo ingredientes ativos
AR011611A1 (es) Composiciones en gel postespumante
UA39896C2 (uk) Фармацевтична або ветеринарна композиція мупіроцину та спосіб її приготування
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
ES2134359T3 (es) Composiciones viscoelasticas de compuestos organicos fluorados.
BR9809057A (pt) Composições antitussìgenas
DE3587358D1 (de) Pharmazeutische zusammensetzungen.
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
AR012217A1 (es) Una composicion topica para mejorar la penetracion de compuestos farmaceuticos
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
ES2038606T3 (es) Una composicion para la preparacion extemporanea de formulaciones destinadas a aplicaciones topicas para uso farmaceutico y cosmetico.
DK0647129T3 (da) Præparat til topisk anvendelse
GEP20053581B (en) Pharmaceutical Composition and Method for Preparation Thereof
WO2001003774A3 (en) Pharmaceutical composition for the treatment of calcification
EP0992242A4 (en) PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS

Legal Events

Date Code Title Description
FG Grant, registration